0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Biochemistry

Buy Now

Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease Microbial Iron Transport Pharmacokinetic Drug Interactions (Paperback, Softcover reprint of the original 1st ed. 1988) Loot Price: R2,752
Discovery Miles 27 520
Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated...

Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease Microbial Iron Transport Pharmacokinetic Drug Interactions (Paperback, Softcover reprint of the original 1st ed. 1988)

William R. Bartle, Volker Braun, John M. Dietschy, Yasufumi Emori, Masatoshi Hagiwara, Hiroyoshi Hidaka, Shinobu Imajoh, Hiroshi Kawasaki, Jonathan B Meddings, Shigeo Ohno

Series: Progress in Clinical Biochemistry and Medicine, 5

 (sign in to rate)
Loot Price R2,752 Discovery Miles 27 520 | Repayment Terms: R258 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Cholesterol is essential for normal cellular function. It is found in all cells of the body and is a major constituent of cell membranes. In addition, certain specialized tissues use cholesterol as the basic substrate for the synthesis of more complicated sterols such as bile acids and the steroid hormones. Like most lipids cholesterol has a very low solubility in water. Therefore, in order for these molecules to be transported be tween different organs of the body a series of lipid carriers known as lipoproteins has evolved. Over the last several years epidemiological evidence has accumulated suggest ing a strong relationship between the risk of atherosclerosis and high plasma concen trations of one of these lipoproteins, low density lipoprotein (LDL) 1). Thus, in popula tions with high plasma concentrations of LDL-cholesterol a correspondingly high incidence of vascular disease is seen. Since it has been demonstrated that reducing the steady-state plasma LDL-cholesterol concentration produces a proportional decrease in the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have been hampered by a lack of knowledge concerning the physiological regulation of the plasma LDL-cholesterol concentration. However, recently there have been several major advances in these areas and it is now possible to precisely determine those factors that have the greatest effect on either increasing or decreasing the plasma LDL-cholesterol concentration."

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Progress in Clinical Biochemistry and Medicine, 5
Release date: March 2012
First published: 1988
Contributors: William R. Bartle • Volker Braun • John M. Dietschy • Yasufumi Emori • Masatoshi Hagiwara • Hiroyoshi Hidaka • Shinobu Imajoh • Hiroshi Kawasaki • Jonathan B Meddings • Shigeo Ohno
Dimensions: 244 x 170 x 8mm (L x W x T)
Format: Paperback
Pages: 134
Edition: Softcover reprint of the original 1st ed. 1988
ISBN-13: 978-3-642-72904-1
Categories: Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
Books > Science & Mathematics > Biology, life sciences > Biochemistry > General
Books > Science & Mathematics > Biology, life sciences > Zoology & animal sciences > General
LSN: 3-642-72904-5
Barcode: 9783642729041

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners